An additional treatment option with TAGRISSO® (osimertinib) (Sponsored)
Jan 10, 2025•14 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Arun Krishna, Vice President and franchise head for an AstraZeneca US OBU, shares details of a treatment option with TAGRISSO® (osimertinib). AstraZeneca is focused on the development of new treatments, prioritizing researching options in eligible patients.
Listen to the full podcast episode to learn more.
Please see Important Safety Information for TAGRISSO.
Please see complete Prescribing Information, including Patient Information for TAGRISSO.
See omnystudio.com/listener for privacy information.
For the best experience, listen in Metacast app for iOS or Android